Corporate Finance Debt Deals Equity Deals M&A Deals
Get a $66bn Smile: Actavis to buy the Botox-maker Allergan
Actavis plc.; market cap (as of 21/11/2014): $70.5bn Allergan Inc.; market cap (as of 21/11/2014): $63.3bn Introduction The growing emphasis we put on health and quality of life, and the scientific advancements which are making this possible, are putting the pharmaceutical and medical industries in the spotlight. The recent surge Read more…